Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt | $31.3M | ($30.6M) | ($79.7M) | ($350.9M) | ($672.8M) | ($1,610.8M) | ($697.3M) | ($4,082.9M) | ($5,908.3M) | ($3,919.6M) | ($2,244.2M) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, BeiGene, Ltd.'s last 12-month Net Debt is ($1,600.5M), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, BeiGene, Ltd.'s Net Debt growth was (38.3%). The average annual Net Debt growth rates for BeiGene, Ltd. have been (27.3%) over the past three years, 11.3% over the past five years.
Over the last year, BeiGene, Ltd.'s Net Debt growth was (38.3%), which is lower than industry growth of (0.1%). It indicates that BeiGene, Ltd.'s Net Debt growth is Good.